AbbVie Announces HUMIRA® (adalimumab) Global Patent License with Momenta ... NORTH CHICAGO, Ill., Nov. 6, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) ...
確定! 回上一頁